−5.81 USD
−14.80 M USD
142.00 K USD
3.01 M
About Serina Therapeutics, Inc.
Sector
CEO
Steven A. Ledger
Website
Headquarters
Huntsville
Founded
2024
FIGI
BBG00HCXQ7B0
Serina Therapeutics, Inc. operates as a pharmaceutical company, which engages in the development of polymer technology. Its POZ technology is designed to optimize drug delivery to maximize compliance, therapeutic outcomes, safety, and quality of life for patients. It also offers drugs to treat neurological diseases, cancer, and pain. The company was founded by J. Milton Harris and Michael D. Bentley on March 26, 2024 and is headquartered in Huntsville, AL.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of SER is 6.13 USD — it has increased by 15.42% in the past 24 hours. Watch Serina Therapeutics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on AMEX exchange Serina Therapeutics, Inc. stocks are traded under the ticker SER.
SER stock has fallen by −9.71% compared to the previous week, the month change is a −4.20% fall, over the last year Serina Therapeutics, Inc. has showed a −98.55% decrease.
SER stock is 43.90% volatile and has beta coefficient of −2.10. Track Serina Therapeutics, Inc. stock price on the chart and check out the list of the most volatile stocks — is Serina Therapeutics, Inc. there?
Today Serina Therapeutics, Inc. has the market capitalization of 42.59 M, it has decreased by −14.10% over the last week.
Yes, you can track Serina Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
SER net income for the last quarter is 1.41 M USD, while the quarter before that showed 5.20 M USD of net income which accounts for −72.91% change. Track more Serina Therapeutics, Inc. financial stats to get the full picture.
No, SER doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 18, 2024, the company has 4.00 employees. See our rating of the largest employees — is Serina Therapeutics, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Serina Therapeutics, Inc. EBITDA is −14.89 M USD, and current EBITDA margin is −6.92 K%. See more stats in Serina Therapeutics, Inc. financial statements.
Like other stocks, SER shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Serina Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Serina Therapeutics, Inc. technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Serina Therapeutics, Inc. stock shows the sell signal. See more of Serina Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.